TrialCard Incorporated, a company involved in access, affordability, adherence, and engagement solutions for patients and healthcare providers, announced yesterday that it has named Karen L Russell as its new chief financial officer, effective immediately.
Russell will assume the role from Interim CFO, Mark Bogovich.
Russell brings to TrialCard more than 20 years of experience in global finance and she has an extensive background in leadership, strategic planning, business operations, change management, and system deployment. She most recently served as CFO for Evidera. Prior to that, she enjoyed a long career in finance at GSK, where her last role was VP, Finance for the Respiratory Business Unit, US Pharma.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer